Główne problemy w żylnej chorobie zakrzepowo-zatorowej Artykuł przeglądowy

##plugins.themes.bootstrap3.article.main##

Anna Kaczyńska

Abstrakt

Nierozpoznanie i niewłączenie w porę leczenia istotnie pogarsza rokowanie w ostrej zatorowości płucnej. Dlatego należy pamiętać o możliwości takiego rozpoznania w diagnostyce różnicowej chorób, zwłaszcza kardiologicznych i pulmonologicznych. Artykuł ten jest przeglądem głównych problemów dotyczących diagnostyki, leczenia ostrej fazy i wtórnej profilaktyki u chorych z żylną chorobą zakrzepowo-zatorową.

Pobrania

Dane pobrania nie są jeszcze dostepne

##plugins.themes.bootstrap3.article.details##

Jak cytować
Kaczyńska , A. (2008). Główne problemy w żylnej chorobie zakrzepowo-zatorowej . Kardiologia W Praktyce, 2(4), 135-146. Pobrano z https://journalsmededu.pl/index.php/kwp/article/view/1671
Dział
Artykuły

Bibliografia

1. Koehn H., Koenig B., Mostbeck A.: Incidence and clinical feature of pulmonary embolism in patients with deep vein thrombosis: a prospective study. Eur. J. Nucl. Med. 1987, 13: S11-S15.
2. Kakkar V.V., Flanc C., Howe C.T., Clarke M.B.: Natural history of postoperative deep-vein thrombosis. Lancet 1969, 2: 230-232.
3. Wood K.E.: Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002, 121(3): 877-905.
4. Goldhaber S.Z., Visani L., De Rosa M.: Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999, 352(9162): 1386-1389.
5. Morpurgo M., Schmid C., Mandelli V.: Factors influencing the clinical diagnosis of pulmonary embolism: analysis of 229 postmortem cases. Int. J. Cardiol. 1998, 65(supl. I): S79-S82.
6. Mandelli V., Schmid C., Zogno C. et al.: ‘False negatives’ and ‘false positives’ in acute pulmonary embolism: A clinical-postmortem comparison. Cardiologia 1997, 42: 205-210.
7. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on pulmonary embolism, European Society of Cardiology. Eur. Heart J. 2000, 21(16): 1301-1336.
8. Zakrzepy i zatory. Łopaciuk S. (red.). PZWL, 1996.
9. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2008, 29(18): 2276-2315.
10. Stein P.D., Dalen J.E. McIntyre K.M. et al.: The electrocardiogram in acute pulmonary embolism. Prog. Cardiovasc. Dis. 1975, 17(4): 247-257.
11. Pruszczyk P., Szulc M., Horszczaruk G., Gurba H., Kobylecka M.: Right ventricular infarction in a patient with acute pulmonary embolism and normal coronary arteries. Arch. Intern. Med. 2003, 163(9): 1110-1111.
12. Coma-Canella I., Gamallo C., Martinez Onsurbe P., Lopez-Sendon J.: Acute right ventricular infarction secondary to massive pulmonary embolism. European Heart Journal 1988, 9(5): 534-540.
13. Morpurgo M.: Pulmonary embolism. Marcel Dekker Inc., New York 1994.
14. Stein P.D.: COPD, pulmonary embolism, and death. Chest 1996, 110(5): 1135-1136.
15. McIntyre K.M., Sasahara A.A.: The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am. J. Cardiol. 1971, 28: 288-294.
16. Gallus A., Tillet A., Jackson J., Mills W., Wycherely A.: Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 1986, 2: 1293-1296.
17. Schmitz-Rhode T. et al.: Massive PE: percutaneous emergency treatment by pigtail rotation catheter. J. Ann. Coll. Cardiol. 2000, 36: 375-380.
18. Urokinase Pulmonary Embolism Trial (UPET). A national cooperative study. Circulation 1973, 47(supl.): 1-130.
19. Dalla-Volta S., Palla A., Santolicandro A., Giuntini C. et al.: PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J. Am. Coll. Cardiol. 1992, 20(3): 520-526.
20. Maneveau N., Schiele F., Vuillemenot A., Valette B. et al.: Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur. Heart J. 1997, 18: 1141-1148.
21. Lee A.Y.Y., Levine M.N., Baker R.I. et al. (For the CLOT Investigators): Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N. Engl. J. Med. 2003, 349: 146-153.
22. Kucher N., Quiroz R., McKean S., Sasahara A.A., Goldhaber S.Z.: Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc. Med. 2005, 10(4): 251-256.
23. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992, 340: 873-876.
24. Schulman S., Rhedin A.S., Lindmarker P. et al.: A comparison of six weeks with six months of oral anticoagulant therapy after first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N. Engl. J. Med. 1995, 332: 1661-1665.
25. Levine M.N., Hirsh J., Gent M. et al.: Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb. Haemost. 1995, 74: 606-611.
26. Douketis J.D., Foster G.A., Crowther M.A., Prins M.H., Ginsberg J.S.: Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch. Intern. Med. 2000, 160: 3431-3437.
27. Franzoni P. et al.: Thromboembolus migrating into the right heart in pulmonary embolism. Echocardiographic and clinico-therapeutic aspects in 7 cases and review of the literature. G. Ital. Cardiol. 1989, 19: 7-16.
28. Konstantinides S., Geibel A., Tiede N., Just H.: Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998, 97: 1946-1951.
29. Torbicki A., Pruszczyk P., Kurzyna M.: Pulmonary embolism: role of echocardiography and biological markers. Ital. Heart J. 2005, 6: 805-810.
30. Torbicki A., Galie N., Covezzoli A., Rossi E., Goldhaber SZ. (ICOPER study group): Right heart thrombi in pulmonary embolism. J. Am. Coll. Cardiol. 2003, 1: 2245-2251.
31. Casazza F., Roncon L., Greco F.: Pulmonary embolism: treatment of the acute episode. Ital. Heart J. 2005, 6(10): 816-823.
32. Enzweiler C. et al.: Electron beam tomography of interpulmonary saddle embolism. J. Comput. Assist. Tomogr. 2002, 26: 26-32.
33. Kaczyńska A., Pacho R., Bochowicz A. et al.: Czy zator jeździec obciąża rokowanie u chorych z ostrą zatorowością płucną? Kardiol. Pol. 2005, 62: 124-127.
34. Pruszczyk P. et al.: Short-term clinical outcome of acute saddle PE. Heart 2003, 98: 335-336.
35. Greer I.A.: Venous thromboembolism and anticoagulant therapy in pregnancy. Gend. Med. 2005, 2(supl.): S10-7.
36. De Stefano V., Martinelli I., Rossi E., Battaglioli T., Mannucci P., Leone G.: The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br. J. Haematol. 2006, 135(3): 386-391.
37. Geets W.H., Pineo G.F. Heit J.A. et al.: Prevention of venous thromboembolism. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004, 126 (supl.): 338-400.
38. Kokturk N., Oguzulgen I.K., Demir N. et al.: Differences in clinical presentation of pulmonary embolism in older vs younger patients. Circ. J. 2005, 69(8): 981-986.
39. Stein P.D., Henry J.W.: Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest 1997, 112: 974-979.
40. Punukollu H., Khan I.A., Punukollu G. et al.: Acute pulmonary embolism in elderly: clinical characteristic and outcome. Int. J. Cardiol. 2005, 99(2): 216-313.
41. Kelly J., Rudd A., Levis R.R. et al.: Plasma D-dimers in the diagnosis of venous thromboembolism. Arch. Intern. Med. 2002, 162(7): 747-756.
42. Righini M., Le Gal G., Perrier A. et al.: The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies. J. Am. Geriatr. Soc. 2005, 53(6): 1039-1045.
43. Levine M.N., Hirsh J., Landefeld S. et al.: Hemorrhagic complications of anticoagulant treatment. Chest 1992, 102(4 supl.): 352-363.